Emerging Class III Antiarrhythmic Agents:Mechanism of Action and Proarrhythmic Potential

Abstract
The goal of developing an antiarrhythmic agent effective against malignant ventricular arrhythmias while maintaining a low side-effect profile remains elusive. The class III drugs amiodarone and...

This publication has 0 references indexed in Scilit: